Perceptive Advisors - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 67 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$23,140,000
-68.0%
501,509
-41.8%
0.46%
-16.8%
Q4 2021$72,384,000
+32.7%
861,088
-18.0%
0.56%
-4.6%
Q4 2020$54,537,000
+58.9%
1,050,0030.0%0.58%
+16.8%
Q3 2020$34,325,000
-25.0%
1,050,0030.0%0.50%
-32.5%
Q2 2020$45,783,0001,050,0030.74%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders